As of 2026-09-16, the Relative Valuation of Krystal Biotech Inc (KRYS) is 218.58 USD. This relative valuation is based on P/E multiples. With the latest stock price at 336.68 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -35.1%.
The range of the Relative Valuation is 175.79 - 280.62 USD.
| Range | Selected | |
| Trailing P/E multiples | 27.1x - 34.3x | 29.7x |
| Forward P/E multiples | 27.6x - 39.4x | 30.4x |
| Fair Price | 175.79 - 280.62 | 218.58 |
| Upside | -47.8% - -16.7% | -35.1% |
| Date | P/E |
| 2026-09-11 | 42.36 |
| 2026-09-10 | 42.19 |
| 2026-09-09 | 42.50 |
| 2026-09-08 | 42.88 |
| 2026-09-04 | 43.74 |
| 2026-09-03 | 45.35 |
| 2026-09-02 | 45.08 |
| 2026-09-01 | 44.42 |
| 2026-08-31 | 43.87 |
| 2026-08-28 | 42.91 |
| 2026-08-27 | 43.64 |
| 2026-08-26 | 43.92 |
| 2026-08-25 | 43.49 |
| 2026-08-24 | 41.72 |
| 2026-08-21 | 42.31 |
| 2026-08-20 | 41.15 |
| 2026-08-19 | 41.92 |
| 2026-08-18 | 40.63 |
| 2026-08-17 | 40.99 |
| 2026-08-14 | 40.57 |
| 2026-08-13 | 40.09 |
| 2026-08-12 | 40.64 |
| 2026-08-11 | 39.93 |
| 2026-08-10 | 40.48 |
| 2026-08-07 | 39.86 |
| 2026-08-06 | 39.40 |
| 2026-08-05 | 39.77 |
| 2026-08-04 | 39.65 |
| 2026-08-03 | 38.16 |
| 2026-07-31 | 41.65 |
| 2026-07-30 | 44.79 |
| 2026-07-29 | 44.35 |
| 2026-07-28 | 44.47 |
| 2026-07-27 | 42.95 |
| 2026-07-24 | 40.92 |
| 2026-07-23 | 39.98 |
| 2026-07-22 | 41.12 |
| 2026-07-21 | 41.40 |
| 2026-07-20 | 41.41 |
| 2026-07-17 | 43.32 |
| 2026-07-16 | 41.73 |
| 2026-07-15 | 42.76 |
| 2026-07-14 | 41.44 |
| 2026-07-13 | 44.37 |
| 2026-07-10 | 44.66 |
| 2026-07-09 | 45.32 |
| 2026-07-08 | 45.83 |
| 2026-07-07 | 45.00 |
| 2026-07-06 | 45.74 |
| 2026-07-02 | 45.79 |